Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label
Par un écrivain mystérieux
Description
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://www.cdc.gov/mmwr/volumes/69/rr/social-media/rr6909a1_meningococcalVaccination_IMAGE_25Sep20_1200x627.jpg)
Meningococcal Vaccination: Recommendations of the Advisory
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20210420133028153-0386:S0950268821000698:S0950268821000698_fig1.png?pub-status=live)
Immunogenicity and safety of a quadrivalent meningococcal tetanus
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://www.cdc.gov/mmwr/preview/mmwrhtml/figures/r6202a1f1.gif)
Prevention and Control of Meningococcal Disease
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://www.advancesinpediatrics.org/cms/attachment/1212c4bf-dc80-4620-a1c3-abe5571010b0/gr3_lrg.jpg)
Meningococcal Infections in Children and Adolescents - Advances in
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X14011402-gr1.jpg)
Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://www.mdpi.com/vaccines/vaccines-11-00178/article_deploy/html/images/vaccines-11-00178-g001.png)
Vaccines, Free Full-Text
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://www.tandfonline.com/cms/asset/30795088-12a7-42c8-9e40-8ee0ac92509c/khvi_a_1733867_f0001_b.gif)
Full article: Immunogenicity and safety of a booster dose of a
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://journals.healio.com/cms/asset/6ae5417f-b9e6-4add-99b9-3939b1ffbcfd/10.3928_00904481-20130723-11-table1.jpg)
Prevention of Meningococcal Infections in the First 2 Years of
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://www.tandfonline.com/cms/asset/564c6327-b4c3-4d08-acc1-ede657ce068f/khvi_a_1733867_f0002_b.gif)
Full article: Immunogenicity and safety of a booster dose of a
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://cdn.hiv.uw.edu/doc/1128-1/recommendation-conjugate-quadrivalent-meningococcal-vaccine-persons-hiv.jpg)
Core Concepts - Immunizations in Adults - Basic HIV Primary Care
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://www.menveohcp.com/content/dam/cf-pharma/hcp-menveo/en_US/safety/Safety_chart_Mobile.png)
Safety Profile MENVEO [Meningococcal (Groups A, C, Y and W-135
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2011/nejm_2011.364.issue-24/nejmoa1003812/production/images/img_medium/nejmoa1003812_f1.jpeg)
Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41390-023-02478-5/MediaObjects/41390_2023_2478_Fig2_HTML.png)
Quadrivalent meningococcal tetanus toxoid-conjugate booster
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://www.thelancet.com/cms/asset/9170b4d2-c7ca-4440-9776-fd8069f263f1/gr1.jpg)
Outcomes of meningococcal serogroup B disease in children after
![Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20210223191333153-0311:S0950268821000261:S0950268821000261_tab4.png?pub-status=live)
Immunogenicity and safety of a quadrivalent meningococcal tetanus
depuis
par adulte (le prix varie selon la taille du groupe)